[Table/Fig-2]:

Comparison of reduction in pain - Improvement in VAS scores

Follow-up	Reduction of pain from baseline values *
	LLLT Group	Sham control group
Immediate post- LLLT	4.79 ± 0.86 p-value<0.001 (HS)	0.13 ± 0.35 p-value>0.05 (NS)
1st day follow-up	4.58 ± 1.2 p-value<0.001 (HS)	0.17 ± 0.38 p-value>0.05 (NS)
2nd day follow-up	5.41 ± 2.04 p-value<0.001 (HS)	0.48 ± 1.57 p-value>0.05 (NS)
3rd day follow-up	4.72 ± 1.22 p-value<0.001 (HS)	0.79 ± 0.62 p-value>0.05 (NS)

* The improvement in pain was assessed by comparing the VAS scores at each follow-up interval with the baseline (pre-LLLT application) VAS scores